| MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B M Fabbri, R Garzon, A Cimmino, Z Liu, N Zanesi, E Callegari, S Liu, ... Proceedings of the National Academy of Sciences 104 (40), 15805-15810, 2007 | 2018 | 2007 |
| MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly … R Garzon, S Liu, M Fabbri, Z Liu, CEA Heaphy, E Callegari, S Schwind, ... Blood, The Journal of the American Society of Hematology 113 (25), 6411-6418, 2009 | 925 | 2009 |
| miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts AM Eiring, JG Harb, P Neviani, C Garton, JJ Oaks, R Spizzo, S Liu, ... Cell 140 (5), 652-665, 2010 | 701 | 2010 |
| The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein P Neviani, R Santhanam, R Trotta, M Notari, BW Blaser, S Liu, H Mao, ... Cancer cell 8 (5), 355-368, 2005 | 596 | 2005 |
| Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine W Blum, R Garzon, RB Klisovic, S Schwind, A Walker, S Geyer, S Liu, ... Proceedings of the National Academy of Sciences 107 (16), 7473-7478, 2010 | 592 | 2010 |
| A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia JC Byrd, G Marcucci, MR Parthun, JJ Xiao, RB Klisovic, M Moran, TS Lin, ... Blood 105 (3), 959-967, 2005 | 481 | 2005 |
| FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia P Neviani, R Santhanam, JJ Oaks, AM Eiring, M Notari, BW Blaser, S Liu, ... The Journal of clinical investigation 117 (9), 2408-2421, 2007 | 431 | 2007 |
| Curcumin is a potent DNA hypomethylation agent Z Liu, Z Xie, W Jones, RE Pavlovicz, S Liu, J Yu, P Li, J Lin, JR Fuchs, ... Bioorganic & medicinal chemistry letters 19 (3), 706-709, 2009 | 391 | 2009 |
| Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia W Blum, RB Klisovic, B Hackanson, Z Liu, S Liu, H Devine, ... Journal of Clinical Oncology 25 (25), 3884-3891, 2007 | 381 | 2007 |
| Pro-and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells J Yu, M Wei, B Becknell, R Trotta, S Liu, Z Boyd, MS Jaung, BW Blaser, ... Immunity 24 (5), 575-590, 2006 | 305 | 2006 |
| CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets J Yu, HC Mao, M Wei, T Hughes, J Zhang, I Park, S Liu, S McClory, ... Blood, The Journal of the American Society of Hematology 115 (2), 274-281, 2010 | 302 | 2010 |
| Sp1/NFκB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia S Liu, LC Wu, J Pang, R Santhanam, S Schwind, YZ Wu, CJ Hickey, J Yu, ... Cancer cell 17 (4), 333-347, 2010 | 294 | 2010 |
| Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia L Yu, C Liu, J Vandeusen, B Becknell, Z Dai, YZ Wu, A Raval, TH Liu, ... Nature genetics 37 (3), 265-274, 2005 | 290 | 2005 |
| Prognostic Significance of Expression of a Single MicroRNA, miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study S Schwind, K Maharry, MD Radmacher, K Mrózek, KB Holland, ... Journal of clinical oncology 28 (36), 5257-5264, 2010 | 231 | 2010 |
| Close association of RNA polymerase II and many transcription factors with Pol III genes D Raha, Z Wang, Z Moqtaderi, L Wu, G Zhong, M Gerstein, K Struhl, ... Proceedings of the National Academy of Sciences 107 (8), 3639-3644, 2010 | 217 | 2010 |
| Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation A Mishra, S Liu, GH Sams, DP Curphey, R Santhanam, LJ Rush, ... Cancer cell 22 (5), 645-655, 2012 | 214 | 2012 |
| Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity G Marcucci, W Stock, G Dai, RB Klisovic, S Liu, MI Klisovic, W Blum, ... Journal of clinical oncology 23 (15), 3404-3411, 2005 | 187 | 2005 |
| The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted … SP Whitman, S Liu, T Vukosavljevic, LJ Rush, L Yu, C Liu, MI Klisovic, ... Blood 106 (1), 345-352, 2005 | 185 | 2005 |
| Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia S Liu, T Shen, L Huynh, MI Klisovic, LJ Rush, JL Ford, J Yu, B Becknell, ... Cancer research 65 (4), 1277-1284, 2005 | 173 | 2005 |
| Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia J Yu, Y Peng, LC Wu, Z Xie, Y Deng, T Hughes, S He, XK Mo, M Chiu, ... PloS one 8 (2), e55934, 2013 | 172 | 2013 |
